LGD 4033 - PharmaQO [60caps/12mg]

LGD 4033 (Ligandrol) PharmaQO for sale in the UK

LGD-4033, sold under the research name Ligandrol, is one of the most potent selective androgen receptor modulators (SARMs) on the UK market and is popular with lifters chasing lean mass gains without the full hormonal load of injectable AAS. If you want to buy LGD 4033 UK from a verified source, every PharmaQO bottle sold here contains 60 capsules at 12 mg each, lab-tested and dispatched same working day from our UK warehouse.

What is LGD-4033 (Ligandrol)?

LGD-4033 is a non-steroidal selective androgen receptor modulator originally developed by Ligand Pharmaceuticals and later progressed by Viking Therapeutics for clinical research into muscle wasting and osteoporosis. Unlike anabolic-androgenic steroids, SARMs preferentially activate androgen receptors in muscle and bone while showing weaker activity in the prostate, skin and scalp — the goal being a high anabolic-to-androgenic ratio with fewer side effects. Ligandrol's active half-life is around 24–36 hours, which means once-daily oral dosing produces steady plasma levels. Clinical trials used 0.1–2 mg/day; performance use sits much higher at 5–10 mg/day. Ligandrol is on the WADA prohibited list and is detectable in tested sport.

LGD 4033 benefits

• Strong lean mass gains — one of the most anabolic SARMs at typical performance doses
• No aromatisation — no estrogen-related water retention or gyno risk
• Oral capsule format with once-daily dosing thanks to the long half-life
• Useful for bulking, recomposition and bridging between injectable cycles
• Lower androgenic load than testosterone-based protocols

The 12 mg PharmaQO capsule lets users split or stack the dose flexibly across the standard 5–10 mg/day window without breaking tablets.

LGD 4033 dosage and cycle

Beginners: 5 mg/day. Intermediate: 8–10 mg/day. Advanced: up to 10 mg/day — going higher rarely improves results and steepens suppression. Cycle length is typically 8 weeks, taken once daily with or without food. Onset is gradual, with most users noticing strength and pump changes from week 1–2 and visible recomposition through weeks 4–8. Female use is not recommended at the dose levels stocked here — Ligandrol still carries virilisation potential despite the SARM label.

Side effects and PCT

LGD-4033 is generally well-tolerated but is not side-effect free. HPTA suppression is dose-dependent and significant at 5–10 mg/day — natural testosterone, LH and FSH typically drop within the first 2–3 weeks and a proper post-cycle therapy is required, not optional. Wikipedia notes case reports of hepatotoxicity in non-medical Ligandrol use, so liver values should be respected: a basic liver-support supplement (TUDCA or NAC) for the cycle duration is sensible, particularly if stacking with oral compounds. There is no aromatisation, so an aromatase inhibitor is not required. After the cycle, run a standard SERM-based PCT with PCT Tabs PharmaQO to restart endogenous testosterone production.

Stacks well with

LGD-4033 is most often run as a SARM-only base or stacked with a complementary research compound. Many users pair it with Cardarine GW-501516 for endurance and fat loss during a recomp, or step up to RAD 140 for a harder, more androgenic stack. For a milder first SARM cycle, Ostarine MK-2866 is the standard entry point.

Frequently asked questions

How long does LGD 4033 take to start working?

Most users notice strength gains, fuller pumps and improved recovery from week 1 to 2, with visible lean mass and recomposition effects building through weeks 4 to 8. The 24–36 hour half-life means plasma levels stabilise after a few days of consistent once-daily dosing, so results are smoother than with short-acting orals.

Is LGD 4033 suitable for first-time users?

Ligandrol is on the stronger end of the SARM spectrum, so first-time SARM users are generally better off starting with Ostarine before stepping up. If LGD-4033 is the first cycle, keep the dose at 5 mg/day for 8 weeks, run liver support throughout, and have a full SERM-based PCT ready — suppression is real and recovery without PCT is slow.

Can LGD 4033 be detected on a drug test?

Yes. LGD-4033 is on the WADA prohibited list and is screened for in tested sport. Ligandrol and its metabolites can be detected in urine for several weeks after the last dose with current GC-MS and LC-MS methods. Anyone subject to sport or workplace testing should plan accordingly and not assume SARMs are invisible — they are not.